1. Home
  2. VXRT
  3. VXRT News

Latest Vaxart Inc (VXRT) News on January 22, 2025

Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs
VXRT

GlobeNewswire

8 days ago

Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs

VXRT

MT Newswires

8 days ago

Vaxart Says Oral Covid-19 Vaccine Candidate Recommended for Continued Study

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial
VXRT

GlobeNewswire

9 days ago

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

Vaxart project agreement change ups funding for oral COVID vaccine candidate
VXRT

TipRanks

25 days ago

Vaxart project agreement change ups funding for oral COVID vaccine candidate

VXRT

MT Newswires

a month ago

Top Midday Gainers

VXRT

MT Newswires

a month ago

Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study

VXRT

MT Newswires

2 months ago

Vaxart Completes Sentinel Cohort Enrollment in Phase 2b COVID-19 Vaccine Trial

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
VXRT

GlobeNewswire

2 months ago

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VXRT

GlobeNewswire

2 months ago

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vaxart Third Quarter 2024 Earnings: Beats Expectations
VXRT

Simply Wall St.

2 months ago

Vaxart Third Quarter 2024 Earnings: Beats Expectations

Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and ...
VXRT

GuruFocus.com

2 months ago

Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and ...

VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates
VXRT

Zacks

2 months ago

VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates

Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
VXRT

GlobeNewswire

2 months ago

Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results

Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13
VXRT

GlobeNewswire

2 months ago

Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13

Investing in Vaxart (NASDAQ:VXRT) five years ago would have delivered you a 127% gain
VXRT

Simply Wall St.

3 months ago

Investing in Vaxart (NASDAQ:VXRT) five years ago would have delivered you a 127% gain

Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
VXRT

GlobeNewswire

3 months ago

Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024

Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
VXRT

GlobeNewswire

3 months ago

Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need

Vaxart Inc (VXRT) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Advances
VXRT

GuruFocus.com

3 months ago

Vaxart Inc (VXRT) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Advances

Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
VXRT

GlobeNewswire

4 months ago

Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VXRT

GlobeNewswire

5 months ago

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VXRT

MT Newswires

5 months ago

Vaxart Says Preclinical Data Support Potential Vaccine Against HPV-Related Cervical Dysplasia

Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia
VXRT

GlobeNewswire

5 months ago

Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia

Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
VXRT

Benzinga

5 months ago

Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside

Vaxart Second Quarter 2024 Earnings: Misses Expectations
VXRT

Simply Wall St.

5 months ago

Vaxart Second Quarter 2024 Earnings: Misses Expectations

VXRT

Thomson Reuters StreetEvents

5 months ago

Q2 2024 Vaxart Inc Earnings Call

VAXART, INC. (VXRT) Reports Q2 Loss, Misses Revenue Estimates
VXRT

Zacks

5 months ago

VAXART, INC. (VXRT) Reports Q2 Loss, Misses Revenue Estimates

Vaxart Provides Business Update and Reports Second Quarter 2024 Financial Results
VXRT

GlobeNewswire

5 months ago

Vaxart Provides Business Update and Reports Second Quarter 2024 Financial Results

Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8
VXRT

GlobeNewswire

6 months ago

Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8

While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most
VXRT

Simply Wall St.

7 months ago

While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most

Vaxart Provides Business Update
VXRT

GlobeNewswire

7 months ago

Vaxart Provides Business Update

Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
VXRT

Benzinga

7 months ago

Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering

VXRT

MT Newswires

7 months ago

Vaxart Receives $453 Million for Phase 2b Trial of Covid-19 Oral Pill Vaccine Candidate

VXRT

MT Newswires

7 months ago

Vaxart Launches $40 Million Share Offering; Shares Rise Pre-Bell

Vaxart Announces $40 Million Underwritten Offering of Common Stock
VXRT

GlobeNewswire

7 months ago

Vaxart Announces $40 Million Underwritten Offering of Common Stock

Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
VXRT

GlobeNewswire

7 months ago

Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VXRT

GlobeNewswire

8 months ago

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VXRT

Thomson Reuters StreetEvents

8 months ago

Q1 2024 Vaxart Inc Earnings Call

VXRT

GuruFocus.com

8 months ago

Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...

Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
VXRT

GlobeNewswire

8 months ago

Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results

Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13
VXRT

GlobeNewswire

9 months ago

Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
VXRT

GlobeNewswire

9 months ago

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers

Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
VXRT

GlobeNewswire

10 months ago

Vaxart to Present at World Vaccine Congress Washington 2024 on April 3

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VXRT

GlobeNewswire

10 months ago

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)
VXRT

Simply Wall St.

10 months ago

Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)

Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript
VXRT

Insider Monkey

10 months ago

Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript

VXRT

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Vaxart Inc Earnings Call

Vaxart Inc (VXRT) Reports Full Year 2023 Financial Results
VXRT

GuruFocus.com

10 months ago

Vaxart Inc (VXRT) Reports Full Year 2023 Financial Results

Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
VXRT

GlobeNewswire

10 months ago

Vaxart Provides Business Update and Reports Full Year 2023 Financial Results

Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
VXRT

GlobeNewswire

a year ago

Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14

Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
VXRT

GlobeNewswire

a year ago

Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director

VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy?
VXRT

Zacks

a year ago

VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy?

VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?
VXRT

Zacks

a year ago

VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?

Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge
VXRT

GlobeNewswire

a year ago

Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge

Strong week for Vaxart (NASDAQ:VXRT) shareholders doesn't alleviate pain of three-year loss
VXRT

Simply Wall St.

a year ago

Strong week for Vaxart (NASDAQ:VXRT) shareholders doesn't alleviate pain of three-year loss

Zoomcar Introduces New Product Category with 50% Lower Pricing
VXRT

GlobeNewswire

a year ago

Zoomcar Introduces New Product Category with 50% Lower Pricing

Financial Institutions, Inc. (NASDAQ:FISI) Q4 2023 Earnings Call Transcript
VXRT

Insider Monkey

a year ago

Financial Institutions, Inc. (NASDAQ:FISI) Q4 2023 Earnings Call Transcript

Investar Holding Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
VXRT

Simply Wall St.

a year ago

Investar Holding Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

BRAEMAR HOTELS & RESORTS ANNOUNCES TAX REPORTING INFORMATION FOR 2023 COMMON AND PREFERRED SHARE DISTRIBUTIONS
VXRT

PR Newswire

a year ago

BRAEMAR HOTELS & RESORTS ANNOUNCES TAX REPORTING INFORMATION FOR 2023 COMMON AND PREFERRED SHARE DISTRIBUTIONS

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?
VXRT

Zacks

a year ago

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?

Universal Stainless & Alloy Products, Inc. (NASDAQ:USAP) Q4 2023 Earnings Call Transcript
VXRT

Insider Monkey

a year ago

Universal Stainless & Alloy Products, Inc. (NASDAQ:USAP) Q4 2023 Earnings Call Transcript

VXRT

Associated Press Finance

a year ago

LSI: Fiscal Q2 Earnings Snapshot

LSI Industries Reports Fiscal 2024 Second Quarter Results and Declares Quarterly Cash Dividend
VXRT

Business Wire

a year ago

LSI Industries Reports Fiscal 2024 Second Quarter Results and Declares Quarterly Cash Dividend

Brookline Bancorp Inc (BRKL) Reports Mixed Fourth Quarter Results Amidst Industry Headwinds
VXRT

GuruFocus.com

a year ago

Brookline Bancorp Inc (BRKL) Reports Mixed Fourth Quarter Results Amidst Industry Headwinds

Institutions profited after Omeros Corporation's (NASDAQ:OMER) market cap rose US$23m last week but individual investors profited the most
VXRT

Simply Wall St.

a year ago

Institutions profited after Omeros Corporation's (NASDAQ:OMER) market cap rose US$23m last week but individual investors profited the most

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
VXRT

GlobeNewswire

a year ago

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
VXRT

GlobeNewswire

a year ago

Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management

Vaxart, Inc. Announces Management Change
VXRT

GlobeNewswire

a year ago

Vaxart, Inc. Announces Management Change

Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
VXRT

GlobeNewswire

a year ago

Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024

At US$6.89, Is Immersion Corporation (NASDAQ:IMMR) Worth Looking At Closely?
VXRT

Simply Wall St.

a year ago

At US$6.89, Is Immersion Corporation (NASDAQ:IMMR) Worth Looking At Closely?

VXRT

GlobeNewswire

a year ago

Zoomcar, the World’s Largest Emerging Market Focused Car Sharing Platform, Announces Completion of its Business Combination with Innovative International Acquisition Corporation (IOAC) and Anticipated Nasdaq Listing

Saratoga Investment Corp. to Report Fiscal Third Quarter 2024 Financial Results and Hold Conference Call
VXRT

GlobeNewswire

a year ago

Saratoga Investment Corp. to Report Fiscal Third Quarter 2024 Financial Results and Hold Conference Call

Seismic Industry Veteran Stephen Jumper Joins Geospace Technologies Board of Directors
VXRT

Business Wire

a year ago

Seismic Industry Veteran Stephen Jumper Joins Geospace Technologies Board of Directors

Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers
VXRT

GlobeNewswire

a year ago

Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

Charif Souki, Godfather of American LNG Industry, Is Ousted from Tellurian
VXRT

The Wall Street Journal

a year ago

Charif Souki, Godfather of American LNG Industry, Is Ousted from Tellurian

Retail investors in GlycoMimetics, Inc. (NASDAQ:GLYC) are its biggest bettors, and their bets paid off as stock gained 23% last week
VXRT

Simply Wall St.

a year ago

Retail investors in GlycoMimetics, Inc. (NASDAQ:GLYC) are its biggest bettors, and their bets paid off as stock gained 23% last week

Here's Why You Should Retain OUTFRONT Media (OUT) Stock Now
VXRT

Zacks

a year ago

Here's Why You Should Retain OUTFRONT Media (OUT) Stock Now

Tellurian Board of Directors names Daniel Belhumeur as President, Meredith Mouer as General Counsel and Chief Compliance Officer
VXRT

Business Wire

a year ago

Tellurian Board of Directors names Daniel Belhumeur as President, Meredith Mouer as General Counsel and Chief Compliance Officer

AdTheorent Health Audiences, Powered by HABi™, Earn Neutronian's NQI Certification for Data Quality, Privacy and Transparency
VXRT

PR Newswire

a year ago

AdTheorent Health Audiences, Powered by HABi™, Earn Neutronian's NQI Certification for Data Quality, Privacy and Transparency

Semtech (SMTC) to Release Q3 Earnings: What's in the Cards?
VXRT

Zacks

a year ago

Semtech (SMTC) to Release Q3 Earnings: What's in the Cards?

Favourable Signals For Zevra Therapeutics: Numerous Insiders Acquired Stock
VXRT

Simply Wall St.

a year ago

Favourable Signals For Zevra Therapeutics: Numerous Insiders Acquired Stock

SERA PROGNOSTICS TO PRESENT AT 35TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE
VXRT

PR Newswire

a year ago

SERA PROGNOSTICS TO PRESENT AT 35TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE

Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting
VXRT

Business Wire

a year ago

Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting

Monte Rosa Therapeutics to Present at Piper Sandler Healthcare Conference
VXRT

GlobeNewswire

a year ago

Monte Rosa Therapeutics to Present at Piper Sandler Healthcare Conference

Postal Realty to Present at Nareit’s REITworld 2023
VXRT

GlobeNewswire

a year ago

Postal Realty to Present at Nareit’s REITworld 2023

VXRT

Associated Press Finance

a year ago

FutureFuel: Q3 Earnings Snapshot

FutureFuel Releases Third Quarter 2023 Results
VXRT

GlobeNewswire

a year ago

FutureFuel Releases Third Quarter 2023 Results

LifeLens Technologies Expands Executive Leadership Team and Board of Directors
VXRT

GlobeNewswire

a year ago

LifeLens Technologies Expands Executive Leadership Team and Board of Directors

Here's Why Vaxart (NASDAQ:VXRT) Must Use Its Cash Wisely
VXRT

Simply Wall St.

a year ago

Here's Why Vaxart (NASDAQ:VXRT) Must Use Its Cash Wisely

VXRT

Thomson Reuters StreetEvents

a year ago

Q3 2023 Summit Midstream Partners LP Earnings Call

VXRT

GuruFocus.com

a year ago

Summit Midstream Partners LP (SMLP) Reports Q3 2023 Financial Results: Net Income of $3. ...

Summit Midstream Partners, LP Reports Third Quarter 2023 Financial and Operating Results
VXRT

PR Newswire

a year ago

Summit Midstream Partners, LP Reports Third Quarter 2023 Financial and Operating Results

Share on Social Networks: